: Russia’s Sputnik V COVID-19 vaccine shows 91.6% efficacy in late-stage trial 1 de fevereiro de 2021 by r4ibom in Uncategorized Preliminary findings, published in The Lancet on Tuesday, are based on data gathered from 19,866 participants. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 1 de fevereiro de 2021
